Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Tubulis
company
About
Tubulis Technologies generates uniquely matched protein-drug conjugates.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- €60M
- Industries
- Biotechnology,Health Care,Life Science,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and will collaborate with partners to usher in a new ADC era and deliver better outcomes for patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€70.70M
Tubulis has raised a total of
€70.70M
in funding over 2 rounds. Their latest funding was raised on
May 3, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 3, 2022 | Series B | €60M | 2 | — | — | Detail |
| Jul 21, 2020 | Series A | €10.70M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Tubulis is funded by 2 investors.
Evotec
and Bayern Kapital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Evotec
|
— | Series B |
Bayern Kapital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
